Back to Search
MONIQUE DE BRUIN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1457532731IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A101336(CA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A101336(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SCHOOL OF MEDICINE
Class of 2006
Research & Publications (20)
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
PMID 19667275·J Clin Oncol·2009
4-observational
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.
PMID 19234144·Blood·2009
4-observational
Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
PMID 19535773·J Natl Cancer Inst·2009
8-other
Treatment-related risk factors for premature menopause following Hodgkin lymphoma.
PMID 17890454·Blood·2008
8-other
In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.
PMID 16869820·Br J Clin Pharmacol·2007
8-other
Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
PMID 17425800·BMC Infect Dis·2007
1-meta
Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
PMID 16329159·Pharmacoepidemiol Drug Saf·2006
8-other
Predicting cardiac arrhythmias and sudden death in diabetic users of proarrhythmic drugs.
PMID 15677812·Diabetes Care·2005
8-other
Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research.
PMID 16291479·J Clin Epidemiol·2005
8-other
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
PMID 15637086·Eur Heart J·2005
8-other
Upregulation of platelet derived endothelial cell growth factor/thymidine phosphorylase by interferon alpha.
PMID 15571260·Nucleosides Nucleotides Nucleic Acids·2004
8-other
Sulfasalazine down-regulates the expression of the angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase and interleukin-8 in human monocytic-macrophage THP1 and U937 cells.
PMID 15269287·Mol Pharmacol·2004
8-other
Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
PMID 15571282·Nucleosides Nucleotides Nucleic Acids·2004
8-other
The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylase.
PMID 15140625·Eur J Pharmacol·2004
4-observational
Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells.
PMID 12565833·Biochem Biophys Res Commun·2003
8-other
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.
PMID 12644837·Br J Cancer·2003
8-other
QTc-prolonging drugs and hospitalizations for cardiac arrhythmias.
PMID 12505572·Am J Cardiol·2003
8-other
Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?
PMID 11966667·Br J Clin Pharmacol·2002
8-other
Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival.
PMID 19258500·Cancer Res·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 301 OLD SAN FRANCISCO RD
SUNNYVALE, CA 94086 - Phone
- (650) 934-7811
Quick Facts
- NPI
- 1457532731
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile